Published at Nov 4 2009 12:00AM Category: From Human Resources
The Secretary of Health and Human Services has renewed the declaration that a nationwide public health emergency exists in relation to the H1N1 virus. The Centers for Disease Control (CDC) has designated vaccination as the most powerful public health tool for control of influenza. In keeping with our mission to improve the health, well-being and sense of security of our customers, CIGNA will standardly cover H1N1 flu shot administration in any setting at 100% of the Medicare allowable rate. [1] This 100% coverage will be effective as soon as the FDA approves the release of the new H1N1 vaccine. Deductibles will not apply -- covered individuals will not be asked for a copay or coinsurance. We are expecting the FDA to approve the H1N1 vaccine on or about October 15, 2009 when supplies will be released.
This communication relates to the swine flu vaccine called H1N1 only. Coverage for other vaccines will be in accordance with the individual's plan.
Because the Federal government will be paying for the vaccine itself, CIGNA and other private health plans will only be asked to reimburse for the administration of the vaccine. We expect that both traditional (i.e., physician offices) and non-traditional (e.g., health fair and retail pharmacy) sites will be used as distribution centers for administration of the H1N1 vaccines.
This will be CIGNA's standard approach until the potential for an emergency situation subsides. We will, of course, keep you updated if the situation changes.
By providing first dollar coverage, CIGNA is supporting CDC recommendations and stressing the importance of making every effort to provide vaccination to appropriate individuals across the country.
The Secretary of Health and Human Services has renewed the declaration that a nationwide public health emergency exists in relation to the H1N1 virus. The Centers for Disease Control (CDC) has designated vaccination as the most powerful public health tool for control of influenza. In keeping with our mission to improve the health, well-being and sense of security of our customers, CIGNA will standardly cover H1N1 flu shot administration in any setting at 100% of the Medicare allowable rate. [1] This 100% coverage will be effective as soon as the FDA approves the release of the new H1N1 vaccine. Deductibles will not apply -- covered individuals will not be asked for a copay or coinsurance. We are expecting the FDA to approve the H1N1 vaccine on or about October 15, 2009 when supplies will be released.